Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New fusion tech aims to catch aggressive prostate cancer sooner

NCT ID NCT05064111

First seen Jan 05, 2026 · Last updated May 25, 2026 · Updated 23 times

Summary

This study tests a new software that combines MRI images with real-time ultrasound to help doctors more accurately target and biopsy suspicious prostate lesions. The goal is to improve early detection of aggressive prostate cancer and guide better treatment decisions. The study involves 100 men who already have an MRI and are scheduled for a standard prostate biopsy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Arizona

    Tucson, Arizona, 85724, United States

Conditions

Explore the condition pages connected to this study.